Abstract:Nuclear factor-ĸB (NF-ĸB) transcription factor is a family of essential regulators of the immune response and cell proliferation and transformation. A typical factor is a heterodimer made of either p50 or p52, which are limited processing products of either p105 or p100, respectively, and a member of the Rel family of proteins, typically p65. The transcriptional program of NF-ĸB is tightly regulated by the composition of the dimers. In our previous work, we demonstrated that the ubiquitin ligase KPC1 is involved in ubiquitination and proteasomal processing of p105 to generate p50. Its overexpression and the resulting high level of p50 stimulates transcription of a broad array of tumor suppressors. Here we demonstrate that additional mechanisms are involved in the p50-mediated tumor-suppressive effect. p50 down-regulates expression of a major immune checkpoint inhibitor, the programmed cell death-ligand 1 (PD-L1), both in cells and in tumors. Importantly, the suppression is abrogated by overexpression of p65. This highlights the importance of the cellular quantities of the two different subunits of NF-ĸB which determine the composition of the dimer. While the putative p50 homodimer is tumor-suppressive, the "canonical" p50p65 heterodimer is oncogenic. We found that an additional mechanism is involved in the tumor-suppressive phenomenon: p50 up-regulates expression of the proinflammatory chemokines CCL3, CCL4, and CCL5, which in turn recruit into the tumors active natural killer (NK) cells and macrophages. Overall, p50 acts as a strong tumor suppressor via multiple mechanisms, including overexpression of tumor suppressors and modulation of the tumor microenvironment by recruiting active immune cells.

Mechanism Involved in Cytoplasmic Sequestration of p65 by SIP

Repression of Gene Expression by Unphosphorylated Nf-Kappa B P65 Through Epigenetic Mechanisms

Identification of a Novel Serine/threonine Kinase That Inhibits TNF-induced NF-κB Activation and P53-Induced Transcription

Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway*

[The Effect of Silicon Dioxide on the Activation of Nuclear Factor-Kappab in THP-1 Cells].

P62/sqstm1 Accumulation Due to Degradation Inhibition and Transcriptional Activation Plays a Critical Role in Silica Nanoparticle-Induced Airway Inflammation Via NF-κB Activation

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation

In-cell chemical crosslinking identifies hotspots for SQSTM-1/p62-IκBα interaction that underscore a critical role of p62 in limiting NF-κB activation through IκBα-stabilization

Inducible Phosphorylation of NF-κB p65 at Serine 468 by T Cell Costimulation Is Mediated by IKKϵ*

Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP

SIP, a Novel Ankyrin Repeat Containing Protein, Sequesters Steroid Receptor Coactivators in the Cytoplasm

Selective Regulation of a Defined Subset of Inflammatory and Immunoregulatory Genes by an NF-κB p50-IκBζ Pathway

Phosphorylation of Serine 536 of p65(RelA) Downregulates Inflammatory Responses

Lrrc25 Functions As An Inhibitor Of Nf-Kappa B Signaling Pathway By Promoting P65/Rela For Autophagic Degradation

Negative Regulation of NF- B Signaling by PIAS1

Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-{kappa}B p50-I{kappa}B{zeta} pathway

Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms

Synergistic Regulation of the Acute Phase Protein SIP24/24p3 by Glucocorticoid and Pro-Inflammatory Cytokines.

Small Ubiquitin-Related Modifier 1 is Involved in Hepatocellular Carcinoma Progression Via Mediating P65 Nuclear Translocation

Nuclear factor-kappa B p65-specific small interference RNA inhibits the expression of matrixs metalloproteinase-9 in tumor necrosis factor-alpha and interleukin-1 beta-induced chondrocytes